Servier is already in the process of transforming itself into a much bigger player in cancer, and has just tripled its sales objectives for the category.
California has said it will start selling its own generic version of overdose reversal agent naloxone in another example of the use of government-level purchasing power to
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.